Artisan Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,407,713
Closed -$14.7M 362
2025
Q1
$14.7M Sell
4,407,713
-134,455
-3% -$693K 0.02% 295
2024
Q4
$33.6M Sell
4,542,168
-261,657
-5% -$2.43M 0.05% 269
2024
Q3
$45.1M Sell
4,803,825
-307,584
-6% -$2.91M 0.07% 236
2024
Q2
$41M Sell
5,111,409
-26,813
-0.5% -$287K 0.06% 246
2024
Q1
$76.1M Buy
5,138,222
+310,552
+6% +$3.61M 0.11% 178
2023
Q4
$39.2M Sell
4,827,670
-208,809
-4% -$1.09M 0.06% 236
2023
Q3
$22.9M Buy
5,036,479
+609,738
+14% +$3.98M 0.04% 244
2023
Q2
$31.2M Buy
4,426,741
+858,035
+24% +$6.14M 0.05% 237
2023
Q1
$21.8M Buy
3,568,706
+832,974
+30% +$5.75M 0.04% 253
2022
Q4
$17.5M Sell
2,735,732
-22,841
-0.8% -$178K 0.03% 262
2022
Q3
$26.4M Sell
2,758,573
-20,229
-0.7% -$233K 0.05% 243
2022
Q2
$30.7M Buy
2,778,802
+66,788
+2% +$875K 0.05% 238
2022
Q1
$45.2M Buy
2,712,014
+24,284
+0.9% +$376K 0.06% 239
2021
Q4
$51.3M Sell
2,687,730
-180,565
-6% -$3.98M 0.06% 245
2021
Q3
$70.7M Sell
2,868,295
-106,039
-4% -$2.5M 0.09% 217
2021
Q2
$77.4M Sell
2,974,334
-8,780
-0.3% -$228K 0.09% 206
2021
Q1
$94.4M Buy
2,983,114
+79,645
+3% +$3.3M 0.12% 186
2020
Q4
$135M Buy
2,903,469
+71,231
+3% +$2.83M 0.17% 143
2020
Q3
$93.2M Sell
2,832,238
-157,915
-5% -$4.84M 0.13% 159
2020
Q2
$82.1M Buy
2,990,153
+1,188,943
+66% +$39.1M 0.13% 155
2020
Q1
$53.9M Buy
1,801,210
+156,093
+9% +$4.14M 0.12% 170
2019
Q4
$45.5M Buy
1,645,117
+432,569
+36% +$9.84M 0.08% 193
2019
Q3
$22.1M Buy
1,212,548
+177,152
+17% +$3.92M 0.04% 231
2019
Q2
$25.4M Buy
+1,035,396
New +$15.6M 0.05% 223

Other funds holding IOVA